• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Bradykinin B2 Receptor Antagonist
    1 Drug classified under this drug class


    All the Drug Class Drugs

    Icatibant
    Teva
    RX
    partial basket chart
    Icatibant

    Bradykinin B2 Receptor Antagonist. Icatibant (as acetate) 30 mg / 3 ml.
    SYR. (Sol. for S.C. inj.).: 1. One S.C. inj. of Icatibant (3 ml/30 mg), as soon as signs of attack are detected (e.g. swelling of the skin, especially in the area of the face and neck, or increas. abdom. pain).
    If the condition is not improved in 6 hrs., another 3 ml dose may be admin.
    If there is still no improv., a 3rd dose may be admin. after another 6 hrs.
    No more than 3 doses in 24 hrs. and no more than 8 inj. of icatibant in one month. See lit.
    Tmt. of acute attacks of hereditary angioedema (HAE) in adults 18 yrs. of age and older.
    C/I: Hypersens.

    CLOSE